These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1086174

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Complement (C3) receptor-bearing lymphocyte-mediated cytotoxicity and lymphotoxin responses.
    O'Neill P, Mackler BF, Wyde P.
    Cell Immunol; 1975 Nov; 20(1):33-41. PubMed ID: 1081909
    [No Abstract] [Full Text] [Related]

  • 3. An analysis of lymphocytes with both T-cell marker and IgG or complement receptors in patients with X-linked agammaglobulinemia.
    Chiao JW, Ascensáo J, Pahwa S, Pahwa R, Good RA.
    Clin Immunol Immunopathol; 1976 Sep; 6(2):141-8. PubMed ID: 963912
    [No Abstract] [Full Text] [Related]

  • 4. Lysis of human cultured lymphoblastoid cells by cell-induced activation of the properdin pathway.
    Theofilopoulos AN, Perrin LH.
    Science; 1977 Mar 04; 195(4281):878-80. PubMed ID: 402691
    [Abstract] [Full Text] [Related]

  • 5. Interaction of human lymphocytes with fluid phase human C3b detected by immunofluorescence.
    Simonian S, Molenaar JL, Zeijlemaker WP, Knape JT, Bakker S, Pondman KW.
    Eur J Immunol; 1976 Jan 04; 6(1):52-6. PubMed ID: 823035
    [Abstract] [Full Text] [Related]

  • 6. [Surface receptors in human lymphocytes].
    Nowak J.
    Pol Arch Med Wewn; 1975 Jul 04; 54(1):55-66. PubMed ID: 50596
    [No Abstract] [Full Text] [Related]

  • 7. Relationship between 4a and 4b HLA-determined specificities and C3 receptors of leukocyte membrane.
    Ferreira A, Fotino M, Nussenzweig V.
    Eur J Immunol; 1976 Nov 04; 6(11):832-3. PubMed ID: 1087238
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Studies on the mechanism of the complement-mediated inhibition of the Fc and C3 receptors of B lymphocytes.
    Erdei A, Füst G, Sármay G, Medgyesi GA, Gergely J.
    Clin Immunol Immunopathol; 1977 Nov 04; 8(3):367-76. PubMed ID: 334400
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of the B-lymphocyte population in agammaglobulinemia.
    Geha RS, Gatien JG, Merler E, Rosen FS.
    Birth Defects Orig Artic Ser; 1975 Nov 04; 11(1):36-9. PubMed ID: 1096986
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
    O'Neill PA, Mackler BF, Romsdahl MM.
    J Natl Cancer Inst; 1976 Aug 04; 57(2):431-4. PubMed ID: 1087348
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations.
    Yefenof E, Bakacs T, Einhorn L, Ernberg I, Klein G.
    Cell Immunol; 1978 Jan 04; 35(1):34-42. PubMed ID: 340053
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.